Pinion John Richard
SEC CIK 1648096 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | See Remarks | 133.1K | — | $1.66M | 16 | 2021-10-14 | 2026-04-16 |
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-20 17:16 | 2026-04-16 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | A - Grant | $0.00 | +23.1K | 133.1K | +21% | $0 |
| 2026-03-03 | 2026-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | A - Grant | $0.00 | +11.1K | 119.6K | +10% | $0 | |
| 2026-03-03 | 2026-03-02 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $22.80 | -10.0K | 110.0K | -8% | -$228.7K | |
| DM | 2025-03-04 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | A - Grant | $0.00 | +32.9K | 122.2K | +37% | $0 |
| D | 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $42.10 | -14.4K | 107.8K | -12% | -$607.9K |
| D | 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | F - Tax | $42.92 | -31 | 108.4K | -0.0% | -$1,331 |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $53.76 | -4,173 | 89.3K | -4% | -$224.3K |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | F - Tax | $53.69 | -60 | 93.4K | -0.1% | -$3,221 |
| DM | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | A - Grant | $0.00 | +18.8K | 93.5K | +25% | $0 |
| 2023-05-19 | 2023-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $50.00 | -2,012 | 74.7K | -3% | -$100.6K | |
| DM | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | A - Grant | $0.00 | +24.7K | 61.9K | +66% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $45.26 | -3,755 | 80.2K | -4% | -$170.0K |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | D - Sale to Iss | $45.65 | -4,014 | 76.2K | -5% | -$183.2K |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | A - Grant | $0.00 | +14.0K | 59.3K | +31% | $0 |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $66.62 | -4,498 | 45.3K | -9% | -$299.7K |
| 2021-10-18 | 2021-10-14 | RARE | Ultragenyx Pharmaceutical Inc. | Pinion John Richard | See Remarks | S - Sale | $81.14 | -358 | 49.8K | -0.7% | -$29.0K |
Purchase Sale Sale after option exercise All abbreviations